Simon Draper
@S1monJDraper
Followers
751
Following
663
Media
1
Statuses
188
Professor of Vaccinology and Translational Medicine @UniofOxford | Views own
Oxford, England
Joined June 2017
Exciting data from a human malaria re-challenge model deciphering how humans become immunologically tolerant to falciparum #malaria. Big thanks to fantastic collaborators @spence_lab.
Muñoz Sandoval, Bach, Nahrendorf, Spence et al. @EdinburghUni show that a single #malaria episode reprograms T cell activation to minimize cytotoxicity and injury during subsequent infections. @S1monJDraper
0
2
5
RT @britsocimm: Thanks to global immunisation efforts, an estimated 154 million lives have been saved over the past 50 years 🌎 🤝. That’s eq….
0
4
0
RT @OptiVivax: Great podcast by Andrew Duncan explaining our latest P. vivax malaria challenge clinical trial. Part of the #OptiVivax Conso….
ovg.ox.ac.uk
0
2
0
RT @OptiVivax: #OptiViVax launches a first-in-kind clinical trial, BIO-006, with the @OxfordVacGroup to investigate relapsing malaria infec….
optivivax.web.ox.ac.uk
0
3
0
Our group's new BIO-006 clinical trial on #vivax #malaria is recruiting now in Oxford. The first trial in our @OptiVivax consortium. Aiming to assess relapsing malaria infection - check out the link below 👇.
NEW | The Oxford Vaccine Group has launched a novel clinical study, BIO-006, to investigate relapsing malaria infections caused by Plasmodium vivax. This unique parasite can remain dormant in the liver for months or years, reactivating to cause repeated malaria infections.
0
8
12
RT @EMBLEvents: 📢 Sign up for BioMalPar XXI and join us in this crucial endeavour to understand the biology of the malaria parasite and to….
0
5
0
RT @EMBLEvents: 🦟 #Malaria remains a major global health challenge, with rising deaths and drug resistance adding urgency to the fight. 🌍🤝….
0
12
0
RT @OxfordMedSci: NEWS: First vaccine against blood-stage malaria is well-tolerated and offers effective protection. The study showed that….
medsci.ox.ac.uk
The results of a clinical trial into a new malaria vaccine candidate (RH5.1/Matrix-MTM) show it is well-tolerated and offers effective protection against the blood-stage of the disease - the first...
0
4
0
Big thanks to funders and support from @EDCTP, @USAID, #NIAID, @KavliOxford, @BiochemOxford, @JennerInstitute, @The_MRC, @wellcometrust, @OxfordBRC, and @OxPaediatrics.
0
0
3
Big congrats to H. Magloire Natama, Jo Salkeld, Sarah Silk, @halidou_tinto and Angela Minassian and all the teams who have supported this work @UniofOxford, @URCNNanoro, #NIAID, @LSHTM, @SerumInstIndia, @Novavax, and @ExpreS2ionB.
1
0
3
RH5.1/Matrix-M afforded 55% efficacy against clinical malaria over 6 months when given in a 0-1-5 month regimen, and over 80% efficacy against higher parasitaemia. A big milestone for the field, now enabling us to start multi-stage vaccine clinical trials!.
1
0
1
Delighted to share our first safety and efficacy data on the RH5.1/Matrix-M blood-stage #malaria #vaccine in 5-17 month old children in Burkina Faso published @TheLancetInfDis.
thelancet.com
RH5.1/Matrix-M appears safe and highly immunogenic in African children and shows promising efficacy against clinical malaria when given in a delayed third-dose regimen. This trial is ongoing to...
1
16
38
RT @LSHTM_malaria: Ahead of his retirement lecture today, we celebrate the extraordinary career of Professor Sir Brian Greenwood, a pioneer….
0
23
0
RT @icpvr2025: The French Riviera of the East beckons!!.Come, join us for the 9th ICPvR, hosted by ICMR-VCRC.
0
4
0
RT @Int_S_Vaccines: 🎙️ISV Global Webinar Series .👉6th December 2024 .07:00 (PST) | 1:00 (EST) | 17:00 (South Africa) | 20:30 (IST) . Title….
0
2
0
RT @PasteurEdu: 🦟Exciting News! Registrations are now open for the Malaria MOOC!.👉 Enroll Now : The MOOC provides a….
0
11
0
RT @BiochemOxford: PREVENTION: The Invisible Future of Health - Sir Andrew Pollard.The 17th Unither Baruch Blumberg Lecture.4:30pm Wednesda….
0
3
0
Big congrats to @TheBeiLab, @LatyGaye and their team on the first analysis of #RH5 blood-stage #malaria human #mAbs against P. falciparum clinical isolates in Senegal. Encouraging for strain-transcendence. Check out their great paper @Nature_NPJ below👇.
So excited for this paper to be published, proud of the amazing hard work that went into it, and so grateful for the amazing collaborations that made it all possible! You can get a glimpse “behind the paper” here: Stay tuned for Laty’s thread!.
0
4
20
RT @ZeroMalaria: "Malaria is as old as Egyptian civilization itself, but the disease that plagued pharaohs now belongs to its history and n….
0
20
0
Thank you for inviting me to #ISV2024. An honour to give this plenary talk, and what a fantastic first day of #vaccine research talks and posters!.
Fantastic plenary from Dr. Simon Draper @S1monJDraper from @UniofOxford about the latest in clinical evaluation of most advanced blood stage RH5 malaria vaccine and current clinical development of “next gen” multistage malaria vaccine. #ISV2024
0
2
24